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PreviewsTo address the functional effects of
SNS neuropathy in AML, the authors
treated leukemic mice with adrenergic
b2 and b3 receptor antagonists. b2, but
not b3, adrenergic blockade increased
phenotypic LSC numbers in mice and
reduced survival. In comparison, treat-
ment with a b2 adrenergic receptor
agonist decreased LSC numbers and
resulted in a trend toward increased
survival. The presence of b2 receptors
on MLL-AF9 leukemic cells and their pro-
liferative response to adrenergic stimu-
lation in vitro, however, suggest that a
therapeutic approach to SNS neuropathy
in AML may not be straightforward.
Both studies discussed in this Preview
report on the significance sympathetic
neuropathy plays in malignant cell co-
opting of HSPC niches during disease
progression in AML and MPN. While
loss of catecholaminergic innervation
is central in both diseases, different
sequelae are observed within the niche.
MPN-induced neuropathy alters the
perivascular niche through induction of
apoptosis in Nestin+ MSCs, disrupting
normal HSPC niche regulation and allow-
ing accelerated MPN progression. In262 Cell Stem Cell 15, September 4, 2014 ª2AML, neuropathy induces an increase in
the number of Nestin+ MSCs, which
display an altered osteoblastic lineage
potential and a reduction in HSC niche
supportive factors. Also, in MPN a
clear therapeutic strategy to inhibit
progression is identified by Arranz et al.
(2014) through either the use of neuropro-
tective agents to prevent MPN-induced
neuropathy or the replacement of lost
b3 adrenergic signaling to Nestin+
MSCs via treatment with synthetic ago-
nists. In AML, Hanoun et al. (2014) report
that SNS neuropathy and LSC expan-
sion is mediated by the b2, not b3, adren-
ergic receptor; however, the proliferative
response of b2 receptor+ AML cells to
direct adrenergic stimulation complicates
a therapeutic strategy. Overall, these
studies provide significant new insight
into the role of the SNS in regulating the
HSPC niche and how circumventing its
regulatory capacity is critical for malig-
nant niche transformation in both MPN
and AML. They also highlight the
complexity of the HSPC niche and the
unexpected chain of events that can
ensue from crosstalk amidst its diverse
constituents.014 Elsevier Inc.REFERENCES
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Emerging evidence strongly suggests that stem cells and their differentiated progeny display distinct
metabolic profiles, but how metabolic changes are coupled with organogenesis has remained unclear.
Homem et al. (2014) now reveal a hormone-dependent pathway that couples metabolic changes with stem
cell differentiation, thereby terminating neurogenesis in the Drosophila brain.Work in the past few years has revealed
fundamental differences in metabolic re-
gulation between stem cells and differen-
tiated cells, with proliferating stem cellsrelying more on glycolysis and differen-
tiating cells relying more on oxidative
phosphorylation (Folmes et al., 2012).
Similar to stem cells, cancer cells pre-dominantly rely on aerobic glycolysis,
termed the ‘‘Warburg Effect,’’ for energy
generation. Thus, understanding the
metabolic changes occurring during
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Previewsnormal differentiation can provide critical
insights into tissue development and
homeostasis as well as tumorigenesis.
Homem and colleagues reveal a develop-
mentally controlled pathway that mecha-
nistically links neural stem cell differen-
tiation to changes in cellular growth and
metabolism during Drosophila metamor-
phosis (Homem et al., 2014).
Neurogenesis in the fly brain occurs in
two waves. The second wave of neuro-
genesis occurs throughout larval devel-
opment during which neural stem cells
(neuroblasts) undergo rapid and succes-
sive asymmetric division to generate
differentiated cell types required for
the function of the future adult brain. Dur-
ing metamorphosis, the combination of
cell death and a switch to symmetric
cell division leads to neuroblast loss,
which terminates neurogenesis (Maur-
ange et al., 2008; Siegrist et al., 2010).
Homem and colleagues observed that
after the onset of metamorphosis, neuro-
blasts progressively lose volume after
every asymmetric cell division. This ob-
servation led the authors to hypothesize
that pathways controlling neuroblast
cellular growth might be instructive for
the termination of neuroblast proliferation
during metamorphosis.
Surprisingly, Homem et al. find that
common cellular growth regulatory path-
ways such as insulin and target-of-rapa-
mycin (TOR) signaling do not control the
reduction in neuroblast growth that pre-
cedes symmetric division and cell cycle
exit. To identify the factors that limit
neuroblast size and proliferation, they
perform an RNAi screen covering 70%
of Drosophila protein coding genes. Their
screen uses a high-throughput assay
for persistent neuroblasts, as detected
by perdurant expression of a neuro-
blast-specific luciferase transgene in
adult fly brains. With this assay they
identify several components of the Medi-
ator complex, which delay neuroblast
shrinkage and symmetric division when
knocked down. The steroid hormone
20-hydroxyecdysone plays a central
role in regulating biological responses
during metamorphosis (Yamanaka et al.,
2013). Because the Mediator complex
connects transcription factor complexes
to the RNA Polymerase II holoenzyme
and plays a general role in transcription,
the authors test whether the Mediator
complex might regulate neuroblastgrowth by having it interact with the
Ecdysone receptor. Indeed, they detect
a direct interaction between specific
mediator components and the Ecdysone
receptor, and they uncover a require-
ment for the Mediator complex in the
expression of several Ecdysone-induced
genes.
But, how exactly does this function of
Mediator with steroid hormone signaling
limit neuroblast growth during metamor-
phosis? Homem et al. performed an
RNA sequencing-based transcriptome
analysis of neuroblasts isolated by Fluo-
rescence Activated Cell Sorting (FACS)
from control brains and brains with
reduced Mediator function. Their com-
parative analysis revealed that Mediator
subunits are required for transcriptional
changes in several metabolic enzymes
that occur during normal metamorphosis.
They therefore investigated the role of
these enzymes in reducing neuroblast
growth during metamorphosis. Strikingly,
they find that inhibition of oxidative
phosphorylation, either by reducing an
enzyme that promotes NADH production
upstream in the Krebs cycle or by directly
reducing components of the mitochon-
drial electron transport chain involved
in oxidative phosphorylation prevent
neuroblast shrinkage during metamor-
phosis. Importantly, these deficient neu-
roblasts continue to undergo asymmetric
divisions, thereby increasing the genera-
tion of progeny. The authors suggest
that a switch in metabolism toward
oxidative phosphorylation leads to neuro-
blast shrinkage and symmetric division
coupled with differentiation. In support
of this theory, they observe increased
oxygen consumption rates and reduced
lactate production in the fly brain during
metamorphosis, and they show that
Mediator function is required together
with the Ecdysone receptor for this
change in energy metabolism.
Changes in metabolism, coordinated
with normal cellular differentiation, have
been observed in other organisms and
tissues. For example, in the frog retina, a
switch from glycolysis toward oxidative
phosphorylation is associatedwith cellular
differentiation (Agathocleous et al., 2012).
Reduced oxygen consumption and less
efficient ATP production of aerobic glycol-
ysis might directly contribute to increases
in cellular mass in proliferating tissues
because the products of glycolysis canCell Stem Cell 15, Sbe diverted to pathways for macromole-
cule biosynthesis. Thus, the increased
glycolysis associated with the Warburg
Effect in cancer may be a general feature
of rapidly proliferating tissues.
However, it is seemingly counterin-
tuitive that inhibition of individual com-
ponents of the oxidative phosphorylation
cascade can prolong stem cell division.
This effect suggests that preventing the
metabolic changes associated with dif-
ferentiation feed back onto cell cycle
regulators and delay cell cycle exit.
Such feedback may be unique to stem
cells, as it is precisely opposite the
phenotype observed in somatic cells, as
illustrated by the phenotype of the
tenured mutant fly (Mandal et al., 2005).
In differentiating tenured mutant eye
cells, the cytochrome oxidase subunit
Va is compromised, reducing oxidative
phosphorylation, and the cell cycle be-
comes blocked at the G1-S transition.
Despite this block, cellular growth and
terminal differentiation proceed normally.
In addition, in wild-type Drosophila, two
pathways that promote dramatic prolifer-
ation and cellular growth and delay cell
cycle exit in multiple Drosophila tissues
(CyclinD/Cdk4 and the transcription
factor Yorkie) are thought to increase
mitochondrial biogenesis, fusion, and
mitochondrial membrane potential (Icre-
verzi et al., 2012; Nagaraj et al., 2012).
This mitochondrial phenotype is consis-
tent with increased oxidative phosphory-
lation. How this change may impact
glycolysis and whether these effects of
CyclinD and Yorkie on metabolism also
occur in stem cells remains unclear.
It will be important to compare how
changes in metabolism impact the cell
cycle machinery and vice-versa in stem
versus differentiated cells.
This work suggests that there are pro-
found changes in how metabolism im-
pacts differentiation, cellular growth, and
the cell cycle in stem versus differentiated
cells. This will be an important area for
future research because such metabolic
changes may become co-opted in can-
cers with a stem cell-of-origin or stem-
cell-like features.REFERENCES
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